BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 31237643)

  • 21. The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV
    Calverley PMA; Mueller A; Fowler A; Metzdorf N; Wise RA
    Ann Am Thorac Soc; 2018 Feb; 15(2):200-208. PubMed ID: 28957643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical relevance of fixed ratio vs lower limit of normal of FEV1/FVC in COPD: patient-reported outcomes from the CanCOLD cohort.
    van Dijk W; Tan W; Li P; Guo B; Li S; Benedetti A; Bourbeau J;
    Ann Fam Med; 2015; 13(1):41-8. PubMed ID: 25583891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Dysanapsis With Chronic Obstructive Pulmonary Disease Among Older Adults.
    Smith BM; Kirby M; Hoffman EA; Kronmal RA; Aaron SD; Allen NB; Bertoni A; Coxson HO; Cooper C; Couper DJ; Criner G; Dransfield MT; Han MK; Hansel NN; Jacobs DR; Kaufman JD; Lin CL; Manichaikul A; Martinez FJ; Michos ED; Oelsner EC; Paine R; Watson KE; Benedetti A; Tan WC; Bourbeau J; Woodruff PG; Barr RG;
    JAMA; 2020 Jun; 323(22):2268-2280. PubMed ID: 32515814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed Ratio versus Lower Limit of Normality for Diagnosing COPD in Primary Care: Long-Term Follow-Up of EGARPOC Study.
    Llordés M; Jaen A; Zurdo E; Roca M; Vazquez I; Almagro P;
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1403-1413. PubMed ID: 32606649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mortality and Morbidity Effects of Long-Term Exposure to Low-Level PM
    Brunekreef B; Strak M; Chen J; Andersen ZJ; Atkinson R; Bauwelinck M; Bellander T; Boutron MC; Brandt J; Carey I; Cesaroni G; Forastiere F; Fecht D; Gulliver J; Hertel O; Hoffmann B; de Hoogh K; Houthuijs D; Hvidtfeldt U; Janssen N; Jorgensen J; Katsouyanni K; Ketzel M; Klompmaker J; Hjertager Krog N; Liu S; Ljungman P; Mehta A; Nagel G; Oftedal B; Pershagen G; Peters A; Raaschou-Nielsen O; Renzi M; Rodopoulou S; Samoli E; Schwarze P; Sigsgaard T; Stafoggia M; Vienneau D; Weinmayr G; Wolf K; Hoek G
    Res Rep Health Eff Inst; 2021 Sep; 2021(208):1-127. PubMed ID: 36106702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cut-off value of FEV1/FEV6 as a surrogate for FEV1/FVC for detecting airway obstruction in a Korean population.
    Chung KS; Jung JY; Park MS; Kim YS; Kim SK; Chang J; Song JH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1957-63. PubMed ID: 27578970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Zaigham S; Wollmer P; Engström G
    Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study.
    Tan DJ; Lodge CJ; Walters EH; Bui DS; Pham J; Lowe AJ; Bowatte G; Vicendese D; Erbas B; Johns DP; James AL; Frith P; Hamilton GS; Thomas PS; Wood-Baker R; Han MK; Washko GR; Abramson MJ; Perret JL; Dharmage SC
    Am J Respir Crit Care Med; 2024 Jun; 209(12):1431-1440. PubMed ID: 38236192
    [No Abstract]   [Full Text] [Related]  

  • 30. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease.
    Vaz Fragoso CA; Concato J; McAvay G; Van Ness PH; Rochester CL; Yaggi HK; Gill TM
    Am J Respir Crit Care Med; 2010 Mar; 181(5):446-51. PubMed ID: 20019341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interpreting lung function data using 80% predicted and fixed thresholds identifies patients at increased risk of mortality.
    Mannino DM; Diaz-Guzman E
    Chest; 2012 Jan; 141(1):73-80. PubMed ID: 21659434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measures of bronchodilator response of FEV
    Torén K; Bake B; Olin AC; Engström G; Blomberg A; Vikgren J; Hedner J; Brandberg J; Persson HL; Sköld CM; Rosengren A; Bergström G; Janson C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():973-980. PubMed ID: 28356729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective study of lung function and abdominal aortic aneurysm risk: The Atherosclerosis Risk in Communities study.
    Kubota Y; Folsom AR; Matsushita K; Couper D; Tang W
    Atherosclerosis; 2018 Jan; 268():225-230. PubMed ID: 29079449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impacts of Different Spirometry Reference Equations and Diagnostic Criteria on the Frequency of Airway Obstruction in Adult People of North China.
    Xie M; Cui L; Liu J; Wang W; Li J; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2020; 15():651-659. PubMed ID: 32273694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of the lower limit of normal of FEV1/FVC on survival in lung cancer patients undergoing thoracic surgery.
    Matsuzaki A; Hashimoto N; Okachi S; Taniguchi T; Kawaguchi K; Fukui T; Wakai K; Yokoi K; Hasegawa Y
    Respir Investig; 2016 May; 54(3):184-92. PubMed ID: 27108014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited overlap in significant hits between genome-wide association studies on two airflow obstruction definitions in the same population.
    van der Plaat DA; Vonk JM; Lahousse L; de Jong K; Faiz A; Nedeljkovic I; Amin N; van Diemen CC; Brusselle GG; Bossé Y; Brandsma CA; Hao K; Paré PD; van Duijn CM; Postma DS; Boezen HM
    BMC Pulm Med; 2019 Mar; 19(1):58. PubMed ID: 30845926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of diagnostic criteria on the prevalence of COPD.
    Çolak Y; Løkke A; Marott JL; Lange P; Vestbo J
    Clin Respir J; 2013 Jul; 7(3):297-303. PubMed ID: 23072716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.
    Akkermans RP; Biermans M; Robberts B; ter Riet G; Jacobs A; van Weel C; Wensing M; Schermer T
    Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.